Baricitinib is prescribed for:
- Rheumatoid arthritis (after TNF inhibitor failure)
- Alopecia areata
- Immunology conditions
- Dermatologic autoimmune conditions
Selectively inhibits JAK1 and JAK2.
Back to Medication Guide
Baricitinib
Generic Name: Baricitinib
Brand Names: Olumiant
Baricitinib is a JAK inhibitor for rheumatoid arthritis, alopecia areata, and severe COVID-19.
RheumatologicDermatologicJAK Inhibitor
What It's Used For
Side Effects
Common side effects:
- Upper respiratory infections
- Nausea
- Herpes simplex reactivation
- Acne
Serious side effects (same boxed warnings as tofacitinib):
- Serious infections
- Malignancy
- Thrombosis
- Cardiovascular events
Additional Information
What is Baricitinib?
Baricitinib is a JAK inhibitor that preferentially blocks JAK1 and JAK2.
Alopecia Areata
First systemic treatment approved for severe alopecia areata, showing significant hair regrowth in clinical trials.
Same Class Warnings
Carries same boxed warnings as other JAK inhibitors.
Learn more at MedlinePlus.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Ask Dr. Zimmer
Have questions about Baricitinib? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.